Cover Image
市場調查報告書

腦缺血:全球臨床實驗趨勢

Brain Ischemia Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 239403
出版日期 內容資訊 英文 61 Pages
訂單完成後即時交付
價格
Back to Top
腦缺血:全球臨床實驗趨勢 Brain Ischemia Global Clinical Trials Review, H2, 2016
出版日期: 2016年11月22日 內容資訊: 英文 61 Pages
簡介

本報告提供腦缺血治療藥的臨床試驗相關基本資料和數據,提供您各地區,各階段,各進展狀況的實施數量,並彙整代表性贊助商,開發中的治療藥資訊,全球各國的主要企業·機關的臨床試驗之進展,有潛力的藥劑比較等資訊。

簡介

  • 腦缺血
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主5國的臨床實驗數量
    • 歐洲主5國的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上腦缺血的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上腦缺血的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

腦缺血治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • C. H. Boehringer Sohn AG & Co. KG
    • F. Hoffmann-La Roche Ltd.
    • Bayer AG
    • Prolong Pharmaceuticals
    • NoNO, Inc.
    • 三菱化學控股
    • GlaxoSmithKline plc
    • Edge Therapeutics, Inc.
    • D-Pharm Ltd.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Asan Medical Center
    • China Medical University Hospital
    • Gachon University Gil Hospital
    • UMC Utrecht Holding BV
    • University of Southern California
    • Academic Medical Center
    • Auckland City Hospital
    • Centre hospitalier de l'Universite de Montreal
    • Centre Hospitalier Universitaire de Poitiers
    • Centre Hospitalier Universitaire de Saint Etienne

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3910CTIDB

GlobalData's clinical trial report, "Brain Ischemia Global Clinical Trials Review, H2, 2016" provides an overview of Brain Ischemia clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Ischemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Brain Ischemia to Central Nervous System Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Brain Ischemia to Central Nervous System Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Brain Ischemia Therapeutics Clinical Trials 27
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 58

  • Abbreviations 58
  • Definitions 58
  • Research Methodology 59
  • Secondary Research 59
  • About GlobalData 60
  • Contact Us 60
  • Disclaimer 60
  • Source 61

List of Tables

List of Tables

  • Brain Ischemia Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Brain Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Brain Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • Brain Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Brain Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Brain Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
  • Brain Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
  • Proportion of Brain Ischemia to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14
  • Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Brain Ischemia to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17
  • Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Brain Ischemia Therapeutics, Global, Clinical Trials by Phase, 2016* 20
  • Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
  • Brain Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Brain Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Brain Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Brain Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
  • Brain Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Brain Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Brain Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

List of Figures

  • Brain Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Brain Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Brain Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • Brain Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Brain Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Brain Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
  • Proportion of Brain Ischemia to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14
  • Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Brain Ischemia to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17
  • Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Brain Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
  • Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
  • Brain Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Brain Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Brain Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Brain Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
  • Brain Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Brain Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Brain Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
  • GlobalData Methodology 59
Back to Top